CFM
DFTX

Crawford Fund Management’s Definium Therapeutics DFTX Stock Holding History

Crawford Fund Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Sell
21,200
-275,000
-93% -$4.67M 0.08% 147
2025
Q4 		$3.97M Buy
296,200
+28,700
+11% +$355K 0.52% 61
2025
Q3 		$3.15M Buy
267,500
+54,000
+25% +$504K 0.5% 67
2025
Q2 		$1.39M Buy
213,500
+42,000
+24% +$276K 0.26% 103
2025
Q1 		$1M Sell
171,500
-102,000
-37% -$731K 0.24% 103
2024
Q4 		$1.9M Buy
273,500
+134,000
+96% +$922K 0.33% 91
2024
Q3 		$794K Sell
139,500
-1,100
-0.8% -$7.65K 0.17% 121
2024
Q2 		$1.01M Buy
140,600
+45,800
+48% +$401K 0.26% 99
2024
Q1 		$891K Buy
+94,800
New +$541K 0.21% 108

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return